Feasibility evaluation build. Do not enter patient-identifiable information. SACTCheck highlights how clinician-entered information compares with encoded NCCP criteria; it does not prescribe, authorise or confirm treatment safety. Verify the current NCCP protocol and apply independent clinical judgement.
Search the complete adult solid-tumour library, enter relevant clinical assessment information and review a transparent comparison with encoded protocol criteria. Official NCCP source access remains available throughout.
An independently developed clinician-facing tool designed to make published NCCP regimen criteria easier to find, apply and document during structured oncology assessments.
SACTCheck converts source-linked NCCP regimen criteria into a transparent, structured comparison with clinician-entered laboratory and toxicity information. It shows which encoded criteria are met, not met or unassessed, while keeping the official protocol available for verification.
Day-ward decisions can require rapid review of regimen-specific thresholds, dose-modification guidance, treatment phase and toxicity criteria across lengthy protocol documents. The project aims to improve speed, consistency, transparency and documentation without replacing the treating clinician or the current NCCP source.
This feasibility build uses structured clinical scenarios to assess usability, completion time, clarity of outputs and agreement with independently adjudicated protocol-based answers before any consideration of routine clinical deployment.
Find the current NCCP regimen, confirm the tissue-specific indication and open a structured day-ward assessment.
Adds an oral anti-cancer medicines filter and card badge, expands oral-service search terms and introduces clearer instructions on patient-identifiable information. Protocol JSON and encoded clinical rules are unchanged.
Results update as you type. Press Enter to jump to the first match or / to focus search.
Each tissue page carries a stable icon and colour throughout its catalogue section. Search still covers the entire library.
NCCP 00226 · Version 9
PACLitaxel 80 mg/m² on days 1, 8, 15 and 22 of a 28-day cycle.
NCCP 00209 · Version 10a
Longitudinal blood-count tracking and component-specific dose modification.
NCCP 00227 · Version 9
Irinotecan and 5-FU dose levels, delayed-count nadirs, diarrhoea, stomatitis, renal and hepatic rules.
NCCP 00303 · Version 6
21-day regimen with carboplatin renal checks, hepatic paclitaxel dosing and neuropathy pathways.
NCCP 00624 · Version 3
Platinum-sensitive relapse with haematology, hepatic, PPE, stomatitis and cardiac review pathways.
Local/current source required
No current NCCP SACT regimen was located in the official gynaecology library. Add once the approved local or NCCP protocol is supplied.
NCCP 00321 · Version 9
Mixed IV and oral regimen with count nadirs, renal adjustment, hand-foot syndrome, diarrhoea, stomatitis and oxaliplatin neuropathy rules.
NCCP 00329 · Version 9
Metastatic pancreatic cancer regimen with haematology, renal, hepatic, diarrhoea, stomatitis and oxaliplatin neuropathy rules.
NCCP 00515 · Version 7
Pancreatic cancer regimen with occurrence-based blood-count and component-specific dose modification.
NCCP 00383 · Version 8
Day 1/day 8 assessment with gemcitabine percentage dosing and cisplatin renal branching.
Herskovic · NCCP 00460 · Version 4
Oesophageal chemoradiation with haematology, renal, hepatic and toxicity criteria.
NCCP 00568 · Version 5
First-line metastatic non-squamous NSCLC without EGFR or ALK-positive mutations.
NCCP 00655 · Version 3a
Durvalumab 1500 mg every 28 days after concurrent platinum-based chemoradiation for Stage III NSCLC.
NCCP 00271 · Version 6
21-day regimen for extensive-stage small-cell lung cancer, with IV or IV/oral etoposide schedules.
Boundary implementation: a platelet count of exactly 90 ×10⁹/L is assigned to the protocol row stating platelets ≥90. The subsequent row is implemented as 70 to <90 to avoid overlap.
Open source protocolScope of this prototype: day-1 haematology and delayed-week nadirs, renal/hepatic impairment, DPD status, neuropathy, diarrhoea, stomatitis, laryngo-pharyngeal dysaesthesia and pulmonary warning symptoms. Any modification should be discussed with a Consultant.
Open source protocolScope: haematology and delayed-week nadirs, DPD status, renal/hepatic impairment, diarrhoea and stomatitis.
Open source protocolThis validates the file locally in this browser. It does not upload patient information or permanently publish a protocol.
Preview here first. To publish for all users, place the validated JSON under protocols/ and push it. The repository workflow validates it and rebuilds protocols/index.json.
Clinician-facing NCCP decision support for structured scenario evaluation
This build is being evaluated for feasibility, clarity and usability. It compares information you enter with encoded NCCP protocol criteria and keeps the calculation basis visible for independent review.
Patient-specific protocol explanation
Clinical criteria